Brady Martz Wealth Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Buy
3,572
+10
+0.3% +$574 0.03% 220
2026
Q1
$216K Sell
3,562
-250
-7% -$14.6K 0.04% 185
2025
Q4
$206K Buy
+3,812
New +$183K 0.04% 172
2025
Q2
Sell
-4,293
Closed -$262K 147
2025
Q1
$262K Buy
4,293
+2
+0% +$117 0.06% 130
2024
Q4
$239K Buy
+4,291
New +$240K 0.06% 135

Other funds holding BMY

Brady Martz Wealth Solutions's BMY Position: Q2 2026 in Review

Brady Martz Wealth Solutions increased its Bristol-Myers Squibb (BMY) stake by 0.28% in Q2 2026, buying an estimated $574 and bringing the position to 3,572 shares worth $206K. The position accounts for 0.03% of the portfolio, ranked #220.

Brady Martz Wealth Solutions first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. The position peaked at $262K in Q1 2025. 803 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Brady Martz Wealth Solutions held 3,572 shares of Bristol-Myers Squibb worth $206K as of Q2 2026.
  • Brady Martz Wealth Solutions bought 10 Bristol-Myers Squibb shares in Q2 2026, an estimated $574.
  • Bristol-Myers Squibb made up 0.03% of Brady Martz Wealth Solutions's portfolio in Q2 2026, its #220 holding.
  • Brady Martz Wealth Solutions first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
  • Brady Martz Wealth Solutions's Bristol-Myers Squibb position peaked at $262K in Q1 2025.
  • 803 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Brady Martz Wealth Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.